The Canadian Securities Administrators (CSA) is urging investors to be cautious when considering investing in medical marijuana stocks. A significant number of reporting issuers have announced their intention to begin growing and selling medical marijuana, in conjunction with new regulations enacted by the Government of Canada as of April 1, 2014.
While some have touted medical marijuana as a significant new sector for investment, the CSA has observed a number of small or inactive reporting issuers announcing medical marijuana business plans. In many of these cases, just the announcement of intent to develop a medical marijuana business has resulted in an immediate rise in a company’s stock price. The CSA is concerned investors may face financial harm by purchasing such shares at an inflated price before there is a viable business.
Investors should be aware that companies cannot legally conduct a medical marijuana business without a licence from Health Canada, and that there is likely significant time and cost required to obtain such a licence. For a list of companies that have been granted a licence, please see the Government of Canada website.
If a company is discussing or publicizing its intention to enter the medical marijuana industry, investors should understand what resources it has committed to its plan, as well as the related risks, cost implications and time required before it can begin licenced operations. There is no assurance that a company announcing its intent to enter the medical marijuana industry will be successful in obtaining a licence, or in creating shareholder value.
The United States Securities and Exchange Commission has also issued an alert on this topic. All investors should conduct significant due diligence when considering an investment in the medical marijuana sector, regardless of where the company is located or on which stock exchange it trades.
Report a Concern
If you have any concerns about a person or company offering an investment opportunity, please contact BCSC Inquiries at 604-899-6854 or 1-800-373-6393 or through e-mail at [email protected]. You can also file a complaint or submit a tip anonymously using the BCSC’s online complaint form.
Investor Alert: BCSC Issues Warning About DFRF Enterprises LLC, DFRF Enterprises Ltd. and Daniel Fernandez Rojo Filho
The British Columbia Securities Commission is warning the public not to purchase memberships or other securities of DFRF Enterprises LLC, DFRF Enterprises Ltd., or other companies associated with Daniel Fernandez Rojo Filho. DFRF claims to operate out of Orlando and Vancouver, and is hosting seminars on its purported investments. The BCSC has become aware that […]
The Canadian Securities Administrators (CSA) warn investors about binary options scams.